Oakwood Labs expertise falls under the development, scale-up, and manufacturing of sustained release injectable microsphere formulations. Our patented Chroniject microsphere technology provides tailored solutions for sustained release delivery from feasibility through commerical supply.
R&D Feasibility Capabilities:
- Customizable release duraitons ranging from one week to one year
- Ability to encapuslate small molecules, peptides, and proteins
- Analytical method development and validation
Scale-up Capabilities:
- Lot to lot reproducibility and scalability
- Implementation of QBD and DOE strategies
- Transfer between R&D and GMP facilities
GMP Manufacturing Capabilities:
- FDA approved GMP aseptic manufacturing facility
- Ability to supply Clinical Phase I, II, II and Commerical supply
- In-house QC microbiolodgy and chemistry